UK Contraceptive Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

UK Contraceptive Devices Market is Segmented by Type (Condoms, Diaphragms, Cervical Caps, Vaginal Rings, Intra Uterine Devices (IUDs), and Other Types) and Gender (Male and Female). The report offers the value (in USD million) for the above segments.

UK Contraceptive Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

UK Contraceptive Devices Market Size

View Global Report
United Kingdom Contraceptive Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Market Size (2025) USD 418.57 Million
Market Size (2030) USD 554.87 Million
CAGR (2025 - 2030) 5.80 %
Market Concentration Medium

Major Players

United Kingdom Contraceptive Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of United Kingdom Contraceptive Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

UK Contraceptive Devices Market Analysis

The United Kingdom Contraceptive Devices Market size is estimated at USD 418.57 million in 2025, and is expected to reach USD 554.87 million by 2030, at a CAGR of 5.8% during the forecast period (2025-2030).

  • The COVID-19 pandemic had a negative impact on the growth of the studied market due to disruptions in global supply chains. According to an article published in March 2022 in Contraception and Reproductive Medicine, the use of long-acting contraceptives decreased significantly during the initial phase of the pandemic. Implants decreased by 76%, intrauterine systems by 79%, and intrauterine devices by 76%.
  • Over the first three months of the lockdown, prescriptions for intrauterine and implant contraceptives decreased by 75%, which led to an increase in unwanted pregnancies in the country. A news report published in October 2021 revealed that women were nine times more likely to experience access issues to contraception during the first lockdown. This issue led to a near doubling of unexpected births from 1.3% before the lockdown to 2.1% post-lockdown.
  • However, with the release of COVID-19 restrictions and the resumption of services, the market recovered post-pandemic, and a stable growth rate is expected during the forecast period. Several factors are propelling the market growth, including increasing awareness of sexually transmitted diseases (STDs), rising rates of unintended pregnancies, and an increase in government initiatives. The imperative of reducing unplanned pregnancies and their consequences is the key factor driving market growth in the United Kingdom.
  • One of the significant drivers for this demand is the need to prevent unwanted pregnancies, particularly among teenage women. According to 2021 statistics published by the UK government, 214,256 abortions were reported in England and Wales in 2021. In addition, 89% of abortions were performed in women under 10 weeks in 2021 compared to 88% in the previous year, indicating a rising number of abortions in the country. This trend is expected to increase the demand for contraceptive devices among the population, thereby propelling the market growth.
  • Strategic initiatives by market players also contribute to market growth. For instance, in December 2021, Gedeon Richter UK Ltd became a marketing authorization holder (MAH) for Evra, a once-weekly transdermal contraceptive patch for women of fertile age in the United Kingdom. Such authorizations are expected to increase the availability of contraceptive devices in the country during the forecast period.
  • However, the side effects associated with the use of contraceptive devices are likely to restrain market growth over the forecast period. Despite this limitation, owing to factors such as rising demand for contraceptive devices and increasing awareness about these devices, the studied market is anticipated to witness growth over the analysis period.

UK Contraceptive Devices Industry Overview

The contraceptive devices market in the United Kingdom is characterized by moderate competition. Key players in the industry include AbbVie Inc. (Allergan), Bayer AG, Cooper Surgical Inc., Pfizer, and Reckitt Benckiser, among others. To gain a competitive edge over generic products available in the market, companies are undertaking strategic initiatives such as increasing their investments in research and development of innovative products. This approach allows companies to introduce new and improved products that offer better efficacy and safety, thereby expanding their market share.

UK Contraceptive Devices Market Leaders

  1. CooperSurgical, Inc.

  2. AbbVie Inc. (Allergan)

  3. Pfizer Inc.

  4. Reckitt Benckiser

  5. Bayer AG

  6. *Disclaimer: Major Players sorted in no particular order
United Kingdom Contraceptive Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

UK Contraceptive Devices Market News

  • September 2022: Novo Nordisk, a key player in the pharmaceutical industry, launched an over-the-counter hormone replacement therapy drug in the United Kingdom. This move is expected to expand the company's portfolio and increase its market share in the hormone replacement therapy segment.
  • July 2022: Organon, a global healthcare company, entered into a research collaboration and exclusive license agreement with Cirqle Biomedical, a Denmark-based company, to develop a novel investigational non-hormonal, on-demand contraceptive candidate. This collaboration is expected to leverage the strengths of both companies to develop innovative contraceptive products, thereby expanding their market share in the contraceptive market.

UK Contraceptive Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Prevalence of Sexually Transmitted Diseases and Increasing Awareness about STDs
    • 4.2.2 Rising Rate of Unintended Pregnancies & Rise in Government Initiatives
  • 4.3 Market Restraints
    • 4.3.1 Side Effects Associated with the Use of Contraceptive Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Condoms
    • 5.1.2 Diaphragms
    • 5.1.3 Cervical Caps
    • 5.1.4 Vaginal Rings
    • 5.1.5 Intra Uterine Device (IUD)
    • 5.1.6 Other Types
  • 5.2 By Gender
    • 5.2.1 Male
    • 5.2.2 Female

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AbbVie Inc. (Allergan)
    • 6.1.2 Bayer AG
    • 6.1.3 Cooper Surgical Inc.
    • 6.1.4 Viatris (Mylan Laboratories)
    • 6.1.5 Pfizer Inc.
    • 6.1.6 Teva Pharmaceutical Industries Ltd
    • 6.1.7 DKT International
    • 6.1.8 Pregna International Limited
    • 6.1.9 Reckitt Benckiser
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

UK Contraceptive Devices Industry Segmentation

As per the scope of the report, contraceptive devices have been barriers that attempt to prevent pregnancy by physically preventing sperm from entering the uterus. Contraception is more commonly known as fertility, and birth control is described as the method used to avoid pregnancy. They include male condoms, female condoms, cervical caps, diaphragms, and contraceptive sponges with spermicide. 

The United Kingdom's contraceptive devices market is segmented by type (condoms, diaphragms, cervical caps, vaginal rings, intrauterine devices (IUDs), and other types) and gender (male and female). 

The report offers the value (in USD million) for the above segments.

By Type Condoms
Diaphragms
Cervical Caps
Vaginal Rings
Intra Uterine Device (IUD)
Other Types
By Gender Male
Female
Need A Different Region or Segment?
Customize Now

UK Contraceptive Devices Market Research FAQs

How big is the United Kingdom Contraceptive Devices Market?

The United Kingdom Contraceptive Devices Market size is expected to reach USD 418.57 million in 2025 and grow at a CAGR of 5.80% to reach USD 554.87 million by 2030.

What is the current United Kingdom Contraceptive Devices Market size?

In 2025, the United Kingdom Contraceptive Devices Market size is expected to reach USD 418.57 million.

Who are the key players in United Kingdom Contraceptive Devices Market?

CooperSurgical, Inc., AbbVie Inc. (Allergan), Pfizer Inc., Reckitt Benckiser and Bayer AG are the major companies operating in the United Kingdom Contraceptive Devices Market.

What years does this United Kingdom Contraceptive Devices Market cover, and what was the market size in 2024?

In 2024, the United Kingdom Contraceptive Devices Market size was estimated at USD 394.29 million. The report covers the United Kingdom Contraceptive Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the United Kingdom Contraceptive Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

APAC Fruits & Vegetables Juice Industry Report

Statistics for the 2025 United Kingdom Contraceptive Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. United Kingdom Contraceptive Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.